Related Experiment Video
Updated: May 16, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Clinical practice implications of immunizations after pediatric bone marrow transplant: a literature review
Julie L Luke1, Lisa McDonald, Veronica Jude
1Methodist Children's Hospital, San Antonio, TX 78229, USA. Julie.Luke@MHShealth.com
Insights
Pediatric bone marrow transplant (BMT) survivors need timely immunizations to prevent infections. Many patients miss recommended vaccines, highlighting the need for updated protocols and improved adherence to BMT immunization guidelines.
Area of Science:
- Pediatric Hematology/Oncology
- Immunology
- Infectious Disease Prevention
Background:
- Increasing numbers of pediatric survivors after bone marrow transplant (BMT) necessitate focus on long-term health.
- Protection from infection is critical for immunocompromised BMT recipients.
- Current BMT immunization practices often fall short of recommended guidelines.
Purpose of the Study:
- To review evidence-based research on post-BMT immunization.
- To identify barriers preventing adequate immunization in pediatric BMT patients.
- To compare historical and current BMT immunization guidelines and propose an updated protocol.
Main Methods:
- Conducted a literature review of post-BMT immunization research.
- Analyzed barriers to immunization adherence.
- Compared 2000 and 2011 immunization clinical guidelines for BMT patients.
- Developed an updated clinical protocol and schedule.
Main Results:
- Significant gaps exist in recommended immunizations among pediatric BMT patients globally.
- Barriers to immunization are multifactorial, impacting adherence.
- Existing guidelines require updates to reflect current evidence and improve patient outcomes.
Conclusions:
- An updated, evidence-based immunization protocol and schedule are crucial for pediatric BMT survivors.
- Addressing identified barriers can improve vaccination rates and reduce infection risk.
- Standardizing care and discouraging fragmented follow-up are essential for BMT patient health.
Abstract:
The number of pediatric bone marrow transplants is increasing for malignant and nonmalignant diseases. The number of survivors is also increasing, and their long-term health and protection from infection is increasingly important. To prevent infections, it is standard practice to re-immunize pediatric patients after bone marrow transplant (BMT) using the Centers for Disease Control and Prevention immunization guidelines; however, surveys in the United States and other parts of the world indicate that many BMT patients do not receive all the recommended immunizations. A literature review was conducted to identify research based on evidence for immunization following BMT and to recognize barriers to the process. Also, the immunization clinical guidelines from 2000 and 2011 for patients following BMT were compared and an updated clinical protocol and immunization schedule was developed to reflect the current evidence, encourage a change in practice, and discourage fragmented care.
More Related Videos
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...